- Facultat de Medicina
Center
![Foto de - Facultat de Medicina](/img/noimage.png)
![Foto de Hospital Virgen de la Arrixaca](/img/noimage_org.png)
Hospital Virgen de la Arrixaca
Murcia, EspañaPublications in collaboration with researchers from Hospital Virgen de la Arrixaca (66)
2024
-
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023
Neurologia, Vol. 39, Núm. 2, pp. 196-208
-
Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis
Revista Espanola de Cardiologia
-
Vaccine–carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination
Clinical Research in Cardiology, Vol. 113, Núm. 2, pp. 223-234
2023
-
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 555-563
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60
2022
-
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
Frontiers in immunology, Vol. 13, pp. 842354
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
JAMA Network Open, Vol. 5, Núm. 1
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
BJS Open, Vol. 6, Núm. 1
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies
Neurodegenerative Disease Management, Vol. 11, Núm. 3, pp. 251-261
-
Impact of COVID-19 on the cardiovascular surgery departments in Spain: Analysis of the diagnostic-related groups (SECCE-COVID-19 Study phase 2)
Cirugia Cardiovascular, Vol. 28, Núm. 4, pp. 194-198
-
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
Neurologia, Vol. 36, Núm. 1, pp. 50-60
2020
-
Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 561-568